FDA OKs 2nd phase for Presbia's Flexivue Microlens pivotal

Presbia receives FDA clearance to enroll patients in the 2nd stage of a pivotal study of its Flexivue Microlens for treating presbyopia.

Food & Drug Administration (FDA), Presbia

News Well, Clinical Trials, Optical/Ophthalmic, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AiJj7Q